Implications for treatment selection As combination products become more common, the distinction between insulin and GLP-1 therapy becomes more important, not less
Beyond weight loss, Retatrutide Raw Powder demonstrates superior metabolic improvements including enhanced insulin sensitivity, reduced HbA1c levels, decreased triglycerides and LDL cholesterol, and blood pressure reductions
The GLP-1 analog semaglutide showed similar results in mice by a dose-dependent reduction in binge drinking via the probable mechanism of modulating GABA neurotransmission centrally
In 2025, researchers reported that GLP-1 medications can reduce the risk of sudden death and hospitalization in people with a common type of heart failure
Across the 40 weeks of treatment, weight loss ranged from 6.2 to 8.8 kg (greater than what was seen in early Phase 2 semaglutide trials) (NCT03954834)
Whether you want to maximize muscle growth, enhance fat loss or support bone health both compounds are valuable tools to study growth hormone pathways